NCT00969553View on ClinicalTrials.gov

Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Neoplasms
Interventions
DRUG

BI 6727

Dose level 1

Trial Locations (2)

Unknown

1230.16.886002 Boehringer Ingelheim Investigational Site, Tainan City

1230.16.886001 Boehringer Ingelheim Investigational Site, Taipei

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY